» Articles » PMID: 37391774

Endothelial Progenitor Cell-derived Exosomes Promote Anti-inflammatory Macrophages Via SOCS3/JAK2/STAT3 Axis and Improve the Outcome of Spinal Cord Injury

Overview
Publisher Biomed Central
Date 2023 Jun 30
PMID 37391774
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Macrophage in the spinal cord injury (SCI) area imparts a chronic pro-inflammation effect that challenges the recovery of SCI. Previously, endothelial progenitor cell-produced exosomes (EPC-EXOs) have been noticed to facilitate revascularization and inflammation control after SCI. However, their effects on macrophage polarization remained unclear. This study aimed to investigate the EPC-EXOs' role in macrophage polarization and reveal its underlying mechanism.

Methods: We extracted the macrophages and EPC from the bone marrow suspension of C57BL/L mice by centrifugation. After cell identification, the EPC-EXOs were collected by ultra-high-speed centrifugation and exosome extraction kits and identified by transmission electron microscopy and nanoparticle tracking analysis. Then, macrophages were cultured with EPC-EXOs in different concentrations. We labeled the exosome to confirm its internalization by macrophage and detected the macrophage polarization marker level both in vitro and in vivo. We further estimated EPC-EXOs' protective effects on SCI by mice spinal cord tissue H&E staining and motor behavior evaluation. Finally, we performed RT-qPCR to identify the upregulated miRNA in EPC-EXOs and manipulate its expression to estimate its role in macrophage polarization, SOCS3/JAK2/STAT3 pathway activation, and motor behavior improvement.

Results: We found that EPC-EXOs decreased the macrophages' pro-inflammatory marker expression and increased their anti-inflammatory marker expression on the 7 and 14 days after SCI. The spinal cord H&E staining results showed that EPC-EXOs raised the tissue-sparing area rate significantly after 28 days of SCI and the motor behavior evaluation indicated an increased BMS score and motor-evoked potential by EPC-EXOs treatment after SCI. The RT-qPCR assay identified that miR-222-3P upregulated in EPC-EXOs and its miRNA-mimic also decreased the pro-inflammatory macrophages and increased the anti-inflammatory macrophages. Additionally, miR-222-3P mimic activated the SOCS3/JAK2/STAT3 pathway, and SOCS3/JAK2/STAT3 pathway inhibition blocked miR-2223P's effects on macrophage polarization and mouse motor behavior.

Conclusion: Comprehensively, we discovered that EPC-EXOs-derived miR-222-3p affected macrophage polarization via SOCS3/JAK2/STAT3 pathway and promoted mouse functional repair after SCI, which reveals EPC-EXOs' role in modulation of macrophage phenotype and will provide a novel interventional strategy to induce post-SCI recovery.

Citing Articles

Advancements in extracellular vesicles biomanufacturing: a comprehensive overview of large-scale production and clinical research.

Li Z, Yan J, Li X, Chen H, Lin C, Zhang Y Front Bioeng Biotechnol. 2025; 13:1487627.

PMID: 40046812 PMC: 11879961. DOI: 10.3389/fbioe.2025.1487627.


The Impact of the Competition on miRNA, Proteins, and Metabolites in the Blood Exosomes of the Horse.

Yuan X, Yao X, Zeng Y, Wang J, Ren W, Wang T Genes (Basel). 2025; 16(2).

PMID: 40004554 PMC: 11855450. DOI: 10.3390/genes16020224.


HSPA1A inhibits pyroptosis and neuroinflammation after spinal cord injury via DUSP1 inhibition of the MAPK signaling pathway.

He X, Deng B, Zhang C, Zhang G, Yang F, Zhu D Mol Med. 2025; 31(1):53.

PMID: 39924492 PMC: 11809008. DOI: 10.1186/s10020-025-01086-9.


Stem Cell-Derived Extracellular Vesicle-Mediated Therapeutic Signaling in Spinal Cord Injury.

Poongodi R, Hsu Y, Yang T, Huang Y, Yang K, Lin H Int J Mol Sci. 2025; 26(2).

PMID: 39859437 PMC: 11765593. DOI: 10.3390/ijms26020723.


Exosomal communication: a pivotal regulator of bone homeostasis and a potential therapeutic target.

Ye Q, Cui Y, Wang H, Li L, Chen J, Zhu X Front Pharmacol. 2025; 15:1516125.

PMID: 39764467 PMC: 11700997. DOI: 10.3389/fphar.2024.1516125.


References
1.
Beck K, Nguyen H, Galvan M, Salazar D, Woodruff T, Anderson A . Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain. 2010; 133(Pt 2):433-47. PMC: 2858013. DOI: 10.1093/brain/awp322. View

2.
Singh A, Tetreault L, Kalsi-Ryan S, Nouri A, Fehlings M . Global prevalence and incidence of traumatic spinal cord injury. Clin Epidemiol. 2014; 6:309-31. PMC: 4179833. DOI: 10.2147/CLEP.S68889. View

3.
Liu X, Hao M, Chen Z, Zhang T, Huang J, Dai J . 3D bioprinted neural tissue constructs for spinal cord injury repair. Biomaterials. 2021; 272:120771. DOI: 10.1016/j.biomaterials.2021.120771. View

4.
Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

5.
Curtis E, Martin J, Gabel B, Sidhu N, Rzesiewicz T, Mandeville R . A First-in-Human, Phase I Study of Neural Stem Cell Transplantation for Chronic Spinal Cord Injury. Cell Stem Cell. 2018; 22(6):941-950.e6. DOI: 10.1016/j.stem.2018.05.014. View